• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后选择性晚期停用类固醇

Selective late steroid withdrawal after renal transplantation.

作者信息

Laube Guido F, Falger Jutta, Kemper Markus J, Zingg-Schenk Andrea, Neuhaus Thomas J

机构信息

Nephrology Unit, University Children's Hospital, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.

出版信息

Pediatr Nephrol. 2007 Nov;22(11):1947-52. doi: 10.1007/s00467-007-0576-1. Epub 2007 Sep 14.

DOI:10.1007/s00467-007-0576-1
PMID:17874140
Abstract

Steroid withdrawal (SW) after paediatric renal transplantation (RTPL) is controversial. Selective late SW has been performed in our unit since 1995. The safety and effects of SW were analysed retrospectively in 47 patients undergoing RTPL between 1995 and 2004. Initial immunosuppression consisted of cyclosporine A, azathioprine or mycophenolate mofetil and steroids. Criteria for SW were: (1) stable renal function, (2) time interval after RTPL > or = 1 year, (3) no rejection or time interval after last rejection > or = 1 year and (4) good compliance. SW was performed in 30 patients at an age of 13.5 years (range 4.5-18.5) and 2.2 years (range 1-6.6) after RTPL. After SW, one patient experienced a steroid-sensitive rejection. Follow-up after SW (1.3 year; range 0.25-7.5) showed maintained renal function: glomerular filtration rate at SW and currently was 82 (65-128) and 82 (42-115) ml/min per 1.73 m(2), respectively. The number of patients on antihypertensive treatment did not significantly change (at SW: n = 15; currently: n = 11). Height and body mass index (BMI) remained stable: Median standard deviation score (SDS) for height/BMI at SW and currently was -1.1/0.2 and -0.8/0.1, respectively. Selective late SW was safe regarding renal function and had no significant effect on blood pressure and growth.

摘要

小儿肾移植(RTPL)后停用类固醇(SW)存在争议。自1995年以来,我们科室一直进行选择性晚期SW。对1995年至2004年间接受RTPL的47例患者的SW安全性和效果进行了回顾性分析。初始免疫抑制包括环孢素A、硫唑嘌呤或霉酚酸酯以及类固醇。SW的标准为:(1)肾功能稳定;(2)RTPL后时间间隔≥1年;(3)无排斥反应或上次排斥反应后时间间隔≥1年;(4)依从性良好。30例患者在RTPL后13.5岁(范围4.5 - 18.5岁)和2.2年(范围1 - 6.6年)时进行了SW。SW后,1例患者发生了类固醇敏感型排斥反应。SW后的随访(1.3年;范围0.25 - 7.5年)显示肾功能维持良好:SW时和目前的肾小球滤过率分别为每1.73 m² 82(65 - 128)和82(42 - 115)ml/min。接受降压治疗的患者数量无显著变化(SW时:n = 15;目前:n = 11)。身高和体重指数(BMI)保持稳定:SW时和目前身高/BMI的中位标准差评分(SDS)分别为-1.1/0.2和-0.8/0.1。选择性晚期SW在肾功能方面是安全的,对血压和生长无显著影响。

相似文献

1
Selective late steroid withdrawal after renal transplantation.肾移植后选择性晚期停用类固醇
Pediatr Nephrol. 2007 Nov;22(11):1947-52. doi: 10.1007/s00467-007-0576-1. Epub 2007 Sep 14.
2
Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.早期停用类固醇对小儿肾移植受者是安全有效的。
Pediatr Transplant. 2005 Aug;9(4):456-63. doi: 10.1111/j.1399-3046.2005.00319.x.
3
Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.基于霉酚酸酯的无诱导免疫抑制方案的小儿肾移植:三年后的结果
Transplantation. 2003 Feb 27;75(4):454-61. doi: 10.1097/01.TP.0000045748.95874.64.
4
Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.肾移植后维持性免疫抑制治疗的最小化:比较环孢素A/硫唑嘌呤或环孢素A/霉酚酸酯双联疗法与环孢素A单药疗法——一项随机分组后10年的随访研究。
Transpl Int. 2016 Jan;29(1):23-33. doi: 10.1111/tri.12627.
5
Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.环孢素微乳剂和霉酚酸酯治疗下小儿肾移植受者晚期停用类固醇的前瞻性随机试验
Transplantation. 2009 Mar 27;87(6):934-41. doi: 10.1097/TP.0b013e31819b6d4a.
6
Rejection is a strong graft survival predictor in live donor pediatric renal transplantation using cyclosporine, mycophenolate mofetil, and steroids: 5-year outcomes in a single Mexican center.在使用环孢素、霉酚酸酯和类固醇的活体供体小儿肾移植中,排斥反应是移植肾存活的有力预测指标:墨西哥单一中心的5年结果
Transplant Proc. 2013 May;45(4):1442-4. doi: 10.1016/j.transproceed.2013.02.044.
7
Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.肾移植受者中使用巴利昔单抗、环孢素和霉酚酸酯的早期类固醇撤药方案。
Int Immunopharmacol. 2006 Dec 20;6(13-14):1984-92. doi: 10.1016/j.intimp.2006.07.018. Epub 2006 Aug 10.
8
Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.霉酚酸酯与硫唑嘌呤预防肾移植慢性移植物功能障碍的比较:MYSS随访随机对照临床试验
J Am Soc Nephrol. 2007 Jun;18(6):1973-85. doi: 10.1681/ASN.2006101153. Epub 2007 Apr 25.
9
Can we eliminate both calcineurin inhibitors and steroids?我们能否同时停用钙调神经磷酸酶抑制剂和类固醇?
Transplant Proc. 2010 Nov;42(9 Suppl):S25-8. doi: 10.1016/j.transproceed.2010.07.002.
10
Steroid withdrawal in kidney transplant recipients: is it a safe option?肾移植受者停用类固醇:这是一个安全的选择吗?
Clin Transplant. 1997 Oct;11(5 Pt 2):500-4.

引用本文的文献

1
Steroid withdrawal in renal transplantation.肾移植中的类固醇撤药。
Pediatr Nephrol. 2013 Nov;28(11):2107-12. doi: 10.1007/s00467-012-2391-6. Epub 2013 Jan 4.
2
Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.在实体器官移植中,泼尼松龙和泼尼松的临床药代动力学和药效学。
Clin Pharmacokinet. 2012 Nov;51(11):711-41. doi: 10.1007/s40262-012-0007-8.
3
A study on strategies for improving growth and body composition after renal transplantation.一项关于改善肾移植后生长和身体成分的策略的研究。

本文引用的文献

1
Special issues in pediatric kidney transplantation.小儿肾移植中的特殊问题。
Adv Chronic Kidney Dis. 2006 Jan;13(1):62-9. doi: 10.1053/j.ackd.2005.10.001.
2
Steroid preservation: the rationale for continued prescribing.类固醇药物的保存:持续处方的理论依据
Pediatr Nephrol. 2006 Mar;21(3):305-7. doi: 10.1007/s00467-005-2155-7. Epub 2005 Dec 31.
3
Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil.肾移植患者使用钙调神经磷酸酶抑制剂和霉酚酸酯时停用类固醇的最新荟萃分析。
Pediatr Nephrol. 2010 Apr;25(4):753-62. doi: 10.1007/s00467-010-1458-5. Epub 2010 Feb 12.
4
Outcome after renal transplantation. Part II: quality of life and psychosocial adjustment.肾移植后的结局。第二部分:生活质量与心理社会适应
Pediatr Nephrol. 2008 Aug;23(8):1347-54. doi: 10.1007/s00467-008-0798-x. Epub 2008 Apr 3.
Transplant Proc. 2005 Nov;37(9):3746-8. doi: 10.1016/j.transproceed.2005.09.177.
4
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression.现代免疫抑制时代美国肾移植后的移植后淋巴细胞增生性疾病
Transplantation. 2005 Nov 15;80(9):1233-43. doi: 10.1097/01.tp.0000179639.98338.39.
5
Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.小儿及青少年活体供肾移植受者移植肾存活的决定因素:单中心经验
Pediatr Transplant. 2005 Dec;9(6):763-9. doi: 10.1111/j.1399-3046.2005.00376.x.
6
Steroid elimination is coming of age.类固醇消除技术正在走向成熟。
Pediatr Nephrol. 2006 Jan;21(1):2-4. doi: 10.1007/s00467-005-2042-2. Epub 2005 Oct 20.
7
Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients.小儿肾移植患者无类固醇免疫抑制的一年随访结果。
Pediatr Transplant. 2005 Oct;9(5):589-97. doi: 10.1111/j.1399-3046.2005.00345.x.
8
Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.早期停用类固醇对小儿肾移植受者是安全有效的。
Pediatr Transplant. 2005 Aug;9(4):456-63. doi: 10.1111/j.1399-3046.2005.00319.x.
9
A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003.环孢素和咪唑立宾治疗儿童肾移植后停用类固醇的前瞻性试验:1990年至2003年期间获得的结果
Pediatr Transplant. 2005 Apr;9(2):232-8. doi: 10.1111/j.1399-3046.2005.00255.x.
10
Corticosteroid avoidance in pediatric renal transplantation.小儿肾移植中避免使用皮质类固醇
Pediatr Nephrol. 2005 Mar;20(3):418-26. doi: 10.1007/s00467-004-1786-4. Epub 2005 Feb 3.